Format

Send to

Choose Destination
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024. doi: 10.1007/s00259-017-3670-z.

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

Author information

1
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave, 200 Medical Plaza, Los Angeles, CA, USA.
2
Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
3
Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
4
Department of Nuclear Medicine & Endocrinology, PET-CT Center, St. Vincent's Hospital, Linz, Austria.
5
Institute of Nuclear Medicine, UCL/UCLH, London, UK.
6
Nuclear Medicine Unit, University of Bologna, S. Orsola Hospital Bologna, Bologna, Italy.
7
Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
8
Department of Nuclear Medicine, University Hospital Heidelberg and DKFZ Heidelberg, Heidelberg, Germany.
9
Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
10
Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
11
Department of Nuclear Medicine, University Medical Center, University of Rostock, Rostock, Germany.
12
Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
13
Department of Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
14
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
15
Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
16
Pharmaceutical Radiochemistry, Technische Universität München, Walther-Meißner-Str.3, 85748, Garching, Germany.
17
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave, 200 Medical Plaza, Los Angeles, CA, USA. kherrmann@mednet.ucla.edu.
18
Klinik für Nuklearmedizin, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Germany. kherrmann@mednet.ucla.edu.

Abstract

The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of 68Ga-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of 68Ga-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.

KEYWORDS:

Guideline; PET; PSMA; Prostate cancer; Restaging; Staging

PMID:
28283702
DOI:
10.1007/s00259-017-3670-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center